Literature DB >> 3698078

Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts.

E K Rofstad, A Wahl, C de L Davies, T Brustad.   

Abstract

The growth characteristics of multicellular spheroids, derived from human melanoma xenografts and cultivated in liquid-overlay culture, were studied and compared with those of the parent tumours. Six of the seven melanomas investigated formed spheroids, which grew exponentially up to a volume of 1-2 X 10(7) microns 3 (a diameter of 270-340 microns) before the growth rate tapered off. The morphology of the spheroids varied considerably among the melanomas; some spheroids grew as densely packed, spherical structures of cells whereas others were loosely packed and showed an irregular shape. Central necrosis developed when the spheroids attained a diameter of 150-200 microns. The histological and cytological appearance of the spheroids was remarkably similar to that of the parent xenograft in five of the six cases. The sixth melanoma contained two subpopulations with distinctly different DNA content, one of which was predominant in the spheroids, the other in the tumours. This gave rise to clear histological and cytological differences. The volume-doubling time of the spheroids during the exponential growth phase ranged from 1.7 +/- 0.2 to 2.7 +/- 0.4 days and the fraction of cells in S from 13 +/- 1 to 28 +/- 2%. The volume-doubling time decreased with increasing fraction of cells in S, indicating that the differences in growth rate were due mainly to differences in the growth fraction or to differences in the duration of G1. The spheroid volume-doubling times did not correlate with those of the parent xenografts (Td = 4.2-22.5 days at V = 200 mm3), possibly because the cell loss factors of the xenografts were large and varied among the melanomas. The fractions of cells in G1/G0, S and G2 + M in the spheroids and the xenografts did not correlate either, but were found to be within the same narrow ranges in the spheroids and the xenografts--i.e. 50-80% (G1/G0), 10-30% (S) and 10-20% (G2 + M).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698078     DOI: 10.1111/j.1365-2184.1986.tb00731.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  15 in total

1.  Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines.

Authors:  Anjali Shiras; Arti Bhosale; Anjali Patekar; Varsha Shepal; Padma Shastry
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

3.  Growth advantage ("clonal dominance") of metastatically competent tumor cell variants expressed under selective two- or three-dimensional tissue culture conditions.

Authors:  J W Rak; R S Kerbel
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

4.  ras-Induced up-regulation of CTP:phosphocholine cytidylyltransferase α contributes to malignant transformation of intestinal epithelial cells.

Authors:  Daniel J Arsenault; Byong H Yoo; Kirill V Rosen; Neale D Ridgway
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

5.  Acquired multicellular-mediated resistance to alkylating agents in cancer.

Authors:  H Kobayashi; S Man; C H Graham; S J Kapitain; B A Teicher; R S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Non-Destructive Tumor Aggregate Morphology and Viability Quantification at Cellular Resolution, During Development and in Response to Drug.

Authors:  Cassandra L Roberge; David M Kingsley; Denzel E Faulkner; Charles J Sloat; Ling Wang; Margarida Barroso; Xavier Intes; David T Corr
Journal:  Acta Biomater       Date:  2020-09-29       Impact factor: 8.947

7.  Blood supply in melanoma xenografts is governed by the morphology of the supplying arteries.

Authors:  Jon-Vidar Gaustad; Trude G Simonsen; Kjetil G Brurberg; Else Marie Huuse; Einar K Rofstad
Journal:  Neoplasia       Date:  2009-03       Impact factor: 5.715

8.  Tumor vascularity assessed by magnetic resonance imaging and intravital microscopy imaging.

Authors:  Jon-Vidar Gaustad; Kjetil G Brurberg; Trude G Simonsen; Camilla S Mollatt; Einar K Rofstad
Journal:  Neoplasia       Date:  2008-04       Impact factor: 5.715

9.  High interstitial fluid pressure is associated with tumor-line specific vascular abnormalities in human melanoma xenografts.

Authors:  Trude G Simonsen; Jon-Vidar Gaustad; Marit N Leinaas; Einar K Rofstad
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts.

Authors:  Jon-Vidar Gaustad; Trude G Simonsen; Marit N Leinaas; Einar K Rofstad
Journal:  BMC Cancer       Date:  2012-09-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.